Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

Cybin to Host Virtual R&D Day on February 28, 2023

Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache

Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023

Psyched Wellness Announces Launch of eCommerce Fulfillment with ShipHero8

Psyence and Eden Labs Announce Extraction and Product Development Collaboration

Red Light Holland Updates Acquisition and Development of 100 Acres of Farmland in Ontario, Canada Expanding Its Mushroom Farms Division in North America

Awakn Life Sciences Initiates Investigative Study of Novel Formulation of (S)-ketamine to Assess Dissociative Effect

Cognetivity Neurosciences' CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer's Patients Receiving Disease-Modifying Therapy

PharmAla Biotech granted an Export Permit for 300 grams of LaNeo™ MDMA

Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases

Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

Lobe Sciences Board of Directors Elects to Receive Shares in Lieu of Cash for All Board Fees

Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences